Compliance/Expertise/Focus/Open Collaboration

End-to-End CDMO and Striving for Excellence



  • Founded in July 2005, Porton Pharma Solutions Ltd. (Stock abbreviation: Porton Share; Stock code: 300363) is a leading pharmaceutical CDMO (Contract Development Manufacture Organization) in China. From the early stage of development, Porton has provided global pharmaceutical companies and new drug R&D (Research and Development) institutions with customized R&D.

  • Learn About Porton

Our Values

Customer First! Deliver Excellence. Succeed Through Teamwork. Compassionate Care!


Small Molecule API and Intermediates CDMO Services

To Build the World’s leading Pharma Solutions Platform

Drug Product CDMO Services

Synergizing with Small Molecule API and Intermediates CDMO Services

Biologics CDMO Services

Offering World-Class Gene/Cell Therapeutics Development and Manufacturing Services

Global Partners

Porton is proud to have earned the trust of some of the world’s leading and most innovative pharmaceutical companies and many biotechnology companies across the US, EU and Asia.

Business Cooperation